Patent: 9,097,729
✉ Email this page to a colleague
Summary for Patent: 9,097,729
| Title: | Methods of selecting epidermal growth factor receptor (EGFr) binding agents |
| Abstract: | The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr. |
| Inventor(s): | Freeman; Daniel J. (Newbury Park, CA), Sun; Jilin (Thousand Oaks, CA), Jung; Kenneth H. (Newbury Park, CA), Elliott; Gary S. (Thousand Oaks, CA), Radinsky; Robert (Thousand Oaks, CA) |
| Assignee: | AMGEN INC. (Thousand Oaks, CA) |
| Application Number: | 13/191,227 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,097,729
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2027-10-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
